Recruiting OBSERVATIONAL NCT07151898
PET/CT for Trop2 ADC Response Evaluation NSCLC
Evaluation of Treatment Response to Trop2 ADC by 68Ga-MY6349 PET/CT in NSCLC
Sponsor: The First Affiliated Hospital of Xiamen University
Interventions
68Ga-MY6349 PET/CT
Updated 1 time since 2025 Last updated: Aug 26, 2025 Started: May 1, 2025 Primary completion: May 1, 2027 Completion: May 1, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This observational or N/A phase trial investigates NSCLC and PET/CT and is currently actively recruiting participants. The First Affiliated Hospital of Xiamen University leads this study, which shows 1 recorded version since 2025 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
1 version recorded Recruiting
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- The First Affiliated Hospital of Xiamen University
Data source: The First Affiliated Hospital of Xiamen University
For direct contact, visit the study record on ClinicalTrials.gov .